Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis

ABSTRACT:

SUBMITTER: Kulkarni T 

PROVIDER: S-EPMC10953157 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature